The Veteran's claims for service connection for systemic mastocytosis and essential thrombocythemia were denied as the preponderance of evidence is against a finding that these conditions are related to service or herbicide exposure.,Both conditions were found to be not due to Agent Orange exposure, with no supporting rationale provided in any medical opinion.
The deciding factor: The VA examiners considered all available evidence and concluded that the Veteran's systemic mastocytosis and essential thrombocythemia are less likely than not caused by service or herbicide exposure.
- Claimed conditions
- systemic mastocytosis, essential thrombocythemia
- How they argued it
- Not specified
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 9, 2016
- Citation
- 1643037
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 1643037.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Veteran's essential thrombocythemia is remanded for further evaluation and clarification of its etiology.
- Whole decision: Granted
The Veteran was granted an initial rating of 70 percent for essential thrombocythemia from August 10, 2022, to April 7, 2025. From January 1, 2025, he was granted a TDIU.
- Whole decision: Granted
The Veteran's acute myeloblastic leukemia is granted as presumptively related to exposure at Camp LeJeune. The claim for essential thrombocythemia remains pending and requires a new VA medical opinion.
- Whole decision: Partly granted
The Board denied a higher disability rating for the Veteran's hiatal hernia with GERD and remanded the claim for service connection for essential thrombocythemia.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information. How we handle your email.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.